Health
Drug Combo Could Make Surgery Possible for Some Liver Cancer Patients – Technology Networks
A combination of cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients…
A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Results published July 29 in the journal Nature…
Continue Reading
